SBHI "Leningrad Regional Clinical Hospital" — Saint Petersburg

Public research footprint of SBHI "Leningrad Regional Clinical Hospital", compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Non-small Cell Lung Cancer · Carcinoma, Nonsquamous Non-small-cell Lung · Carcinoma, Squamous Cell, Non-small-cell Lung · Small Cell Lung Cancer (SCLC)

Recently updated registry entries

NCT07742215 — A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients… (Recruiting)
NCT03425643 — Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as… (Active Not Recruiting)
NCT03976323 — Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at SBHI "Leningrad Regional Clinical Hospital"?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.